What is non-invasive prenatal testing (NIPT)?
Non-invasive prenatal testing (NIPT) is a maternal blood test that detects fetal DNA fragments to screen for chromosomal abnormalities such as trisomy 21 (Down syndrome), without invasive procedures.
A single maternal blood sample forms the basis of NIPT, a screening test that isolates and analyzes DNA fragments naturally shed by the fetus into the mother's bloodstream. This genetic material enters maternal circulation as the pregnancy advances, typically from around 9 weeks gestation, allowing clinicians to assess the risk of chromosomal conditions.
NIPT screens primarily for:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Sex chromosome abnormalities in some tests
The key distinction is that NIPT carries no miscarriage risk, unlike invasive procedures such as amniocentesis or chorionic villus sampling. This makes it an attractive option for many expectant parents seeking reassurance about fetal health without procedural hazard to the pregnancy.
Results typically return within 7-14 days and are reported as probability scores. A low-risk result suggests the fetus is unlikely to have the screened conditions, while a high-risk result warrants discussion with a clinician about next steps, which may include confirmatory testing or specialist counseling.
Pregnancy care providers across Kuala Lumpur offer NIPT as part of routine prenatal screening packages. When considering this test, expectant parents benefit from speaking with their healthcare provider about individual risk factors, test limitations, and what results mean for their specific pregnancy. To find prenatal care providers offering NIPT and related screening services in the city, local directories list clinics and medical centers by area and service type.